Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes

Clinical trial NCT02268214 · COMPLETED

Trial details

NCT number: NCT02268214
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2014-11-11
Primary completion: 2017-01-04
Enrollment: 833

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.